The Pennant Group, Inc. (PNTG) Tops Q3 Earnings and Revenue Estimates

Core Insights - The Pennant Group, Inc. reported quarterly earnings of $0.3 per share, exceeding the Zacks Consensus Estimate of $0.29 per share, and showing an increase from $0.26 per share a year ago, resulting in an earnings surprise of +3.45% [1] - The company achieved revenues of $229.04 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.71% and up from $180.69 million year-over-year [2] - The stock has underperformed the market, losing about 4.7% since the beginning of the year compared to the S&P 500's gain of 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.31 on revenues of $273.5 million, and for the current fiscal year, it is $1.14 on revenues of $925.9 million [7] - The estimate revisions trend for The Pennant Group was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Outpatient and Home Healthcare industry, to which The Pennant Group belongs, is currently in the top 18% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]